N@N

Stephen Brozak Maintained (CDTX) at Strong Buy and Held Target at $40 on, Apr 25th, 2024

Stephen Brozak of WBB Securities, Maintained "Cidara Therapeutics, Inc." (CDTX) at Strong Buy and Held Target at $40 on, Apr 25th, 2024.

Stephen has made no other calls on CDTX in the last 4 months.

There is 1 other peer that has a rating on CDTX. Out of the 1 peers that are also analyzing CDTX, 0 agree with Stephen's Rating of Hold.

This is the rating of the analyst that currently disagrees with Stephen

---

• Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy and Held Target at $120 on, Monday, April 8th, 2024